CMS Proposed Model Test Would Lower Drugs Costs for Medicare Part D
What’s new: CMS announces the newly proposed GUARD (Guarding U.S. Medicare Against Rising Drug Costs) Model that would lower costs of certain prescription drugs covered by Medicare Part D, to reflect prices paid in economically comparable countries.
Why it matters: GUARD would help make critical prescriptions more accessible for people with Medicare Part D, better enabling them to follow their prescribed care for optimal health outcomes, and alleviating financial strain on Medicare.
What to expect: CMS is seeking public comment on GUARD through an NPRM, which is available on the Federal Register.
The big picture: This proposed drug model advances the Innovation Center’s commitment to help people with Medicare live healthier lives and promote the sustainability of the Medicare program through more affordable medications; it is part of the Trump Administration’s groundbreaking strategy to tackle rising drug costs for Americans.
Find out more:
|
